市場調查報告書

遺傳性癌症篩檢的全球市場:各診斷類型、技術、終端用戶、地區 - 至2027年的預測及分析

Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography

出版商 The Insight Partners 商品編碼 913795
出版日期 內容資訊 英文 171 Pages
訂單完成後即時交付
價格
Back to Top
遺傳性癌症篩檢的全球市場:各診斷類型、技術、終端用戶、地區 - 至2027年的預測及分析 Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography
出版日期: 2019年09月16日內容資訊: 英文 171 Pages
簡介

全球遺傳性癌症篩檢市場在2018年估算為39億6,774萬美金。在2019年∼2027年間預測將以11.1%的年複合成長率成長,2027年達到98億4,052萬美元的規模。

本報告提供全球遺傳性癌症篩檢市場的相關調查,市場機會和趨勢,成長及阻礙因素,各診斷類型、技術、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • The Insight Partners調查報告的指導
  • 市場區隔

第2章 要點

第3章 調查方法

  • 調查範圍
  • 二次調查
  • 一次調查

第4章 市場情況

  • 概要
  • PEST分析
  • 專家的見解
  • 價格分析
  • 償付方案(美國)
  • 族群篩檢資料

第5章 主要產業動態

  • 主要市場成長要素
  • 主要阻礙市場因素
  • 主要市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 市場收益預測/分析
  • 市場預測/分析
  • 主要企業的成果

第7章 市場分析:診斷的各類型

  • 概要
  • 市場佔有率(2018年、2027年)
  • 切片檢查
  • 影像

第8章 市場分析:各技術

  • 概要
  • 市場佔有率(2018年、2027年)
  • 序列
  • 聚合酵素鏈鎖反應(PCR)
  • 微陣列

第9章 市場分析:各終端用戶

  • 概要
  • 市場佔有率(2018年、2027年)
  • 診斷中心
  • 醫院
  • 診所

第10章 遺市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第11章 競爭情形

  • 概要
  • 市場成長策略(2016年∼2019年)
  • 內部成長策略
  • 無機的成長策略

第12章 企業簡介

  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Incorporated
  • Myriad Genetics, Inc.
  • Cancer Genetics Inc.
  • Invitae Corporation
  • Myogenes
  • Strand Life Sciences Pvt. Ltd.
  • Pathway Genomics Corporation
  • CENTOGENE AG

第13章 附錄

  • 關於The Insight Partners
  • 詞彙表
目錄
Product Code: TIPRE00006578

The global hereditary cancer testing market is expected to reach US$ 9,840.52 Mn in 2027 from US$ 3,967.74 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.

The market for hereditary cancer testing is expected to grow, owing to factors such as increasing prevalence of hereditary cancer and growing awareness about hereditary cancer have been boosting the market over the years. In addition, the growing demand for noninvasive methods of detection are likely to have a positive impact on the growth of the market in the coming years. However, problems in accessing whole genomic data for early detection are likely to have a negative impact on the growth of the market in the coming years.

Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.

Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good health in persons. The technological advances have allowed more significant integration of genomics into health care delivery, facilitating screening and molecular diagnostics along with the precise detection of microbes, and prescription and monitoring of efficiency of more accurate therapeutics. Moreover, the genome-based approaches deliver advantages, and it also come with new susceptibilities and risks concerning cybersecurity. The dependency on genome databases restricts the cyber-attacks by conceding their integrity, taking them hostage, or manipulating the data they contain. Therefore, the problem in accessing the whole genomic data for early detection is expected to create a negative impact on the overall industry at a certain extent.

Global hereditary cancer testing market is segmented by diagnosis type, technology, and end user. On the basis of diagnosis type, the market is segmented into biopsy and imaging. On the basis of technology, the market is segmented into sequencing, PCR, and microarray. Based on end user, the market is segmented into diagnostic centers, hospital, and clinics. In 2018, the imaging held the largest share in the market, by diagnosis type.

Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hereditary cancer testing market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global hereditary cancer testing market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Hereditary Cancer Testing Market - By Diagnosis Type
    • 1.3.2 Global Hereditary Cancer Testing Market - By Technology
    • 1.3.3 Global Hereditary Cancer Testing Market - By End User
    • 1.3.4 Global Hereditary Cancer Testing Market - By Geography

2. Global Hereditary Cancer Testing Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Hereditary Cancer Testing Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Expert Opinions
  • 4.4 Hereditary Cancer Testing - Price Analysis (US$)
  • 4.5 Reimbursement Scenario (US)
  • 4.6 Population Screening Data

5. Global Hereditary Cancer Testing Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Hereditary Cancer
    • 5.1.2 Growing Awareness About Hereditary Cancer
  • 5.2 Key Market Restraints
    • 5.2.1 Problems in Accessing Whole Genomic Data for Early Detection
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Demand for Noninvasive Methods of Detection
  • 5.4 Future Trends
    • 5.4.1 Preference For Personalized Medicines
  • 5.5 Impact Analysis

6. Hereditary Cancer Testing Market - Global Analysis

  • 6.1 Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis
  • 6.2 Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis
  • 6.3 Performance of Key Players

7. Global Hereditary Cancer Testing Market Analysis- by Diagnosis Type

  • 7.1 Overview
  • 7.2 Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)
  • 7.3 Biopsy Market
    • 7.3.1 Overview
    • 7.3.2 Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.3 Blood Sample Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.4 Cheek Swab Sample Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Imaging Market
    • 7.4.1 Overview
    • 7.4.2 Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Hereditary Cancer Testing Market Analysis- by Technology

  • 8.1 Overview
  • 8.2 Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
  • 8.3 Sequencing Market
    • 8.3.1 Overview
    • 8.3.2 Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Polymerase Chain Reaction (PCR) Market
    • 8.4.1 Overview
    • 8.4.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Microarray Market
    • 8.5.1 Overview
    • 8.5.2 Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Hereditary Cancer Testing Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
  • 9.3 Diagnostic Centers Market
    • 9.3.1 Overview
    • 9.3.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.4 Hospitals Market
    • 9.4.1 Overview
    • 9.4.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Clinics Market
    • 9.5.1 Overview
    • 9.5.2 Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

10. Hereditary Cancer Testing Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 10.1 North America Hereditary Cancer Testing Market
    • 10.1.1 Overview
    • 10.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
      • 10.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
    • 10.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    • 10.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.2 Europe Hereditary Cancer Testing Market
    • 10.2.1 Overview
    • 10.2.2 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.2.3 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
      • 10.2.3.1 Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
    • 10.2.4 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    • 10.2.5 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.6 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.2.7 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.1 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.7.2 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.2.7.2.1 UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.2.7.3 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.2.7.4 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.8 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.1 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.8.2 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.2.8.2.1 Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.2.8.3 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.2.8.4 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.9 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.1 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.9.2 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.2.9.2.1 France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.2.9.3 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.2.9.4 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.10 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.2.11 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.3 Asia Pacific Hereditary Cancer Testing Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.3.3 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
      • 10.3.3.1 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
    • 10.3.4 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    • 10.3.5 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.6 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.3.7 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.7.1 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.7.2 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.3.7.2.1 China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.3.7.3 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.3.7.4 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.8 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.8.1 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.8.2 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.3.8.2.1 India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.3.8.3 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.3.8.4 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.9 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.9.1 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.9.2 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.3.9.2.1 Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.3.9.3 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.3.9.4 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.10 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.3.11 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.4 Middle East & Africa Hereditary Cancer Testing Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.4.3 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
      • 10.4.3.1 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
    • 10.4.4 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    • 10.4.5 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.4.6 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.4.7 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.7.1 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.7.2 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.4.7.2.1 South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.4.7.3 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.7.4 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.4.8 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.8.1 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.8.2 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.4.8.2.1 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.4.8.3 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.8.4 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.4.9 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.9.1 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.4.9.2 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.4.9.2.1 UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.4.9.3 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.4.9.4 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 10.5 South And Central America Hereditary Cancer Testing Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10.5.3 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
      • 10.5.3.1 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
    • 10.5.4 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
    • 10.5.5 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.5.6 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
    • 10.5.7 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.7.1 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.7.2 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.5.7.2.1 Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.5.7.3 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.5.7.4 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 10.5.8 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.8.1 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 10.5.8.2 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
        • 10.5.8.2.1 Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
      • 10.5.8.3 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 10.5.8.4 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Hereditary Cancer Testing Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
    • 11.3.2 Product Launch
    • 11.3.3 Product Approval
    • 11.3.4 Others
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview
    • 11.4.2 Partnership
    • 11.4.3 Agreement & Collaboration
    • 11.4.4 Acquisition

12. Hereditary Cancer Testing Market-Key Company Profiles

  • 12.1 Hologic Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Koninklijke Philips N.V.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Overview
    • 12.2.4 Product Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Quest Diagnostics Incorporated
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Myriad Genetics, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 Product Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cancer Genetics Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 Product Portfolio
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Invitae Corporation
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Financial Overview
    • 12.6.4 Product Portfolio
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Myogenes
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 Product Portfolio
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Strand Life Sciences Pvt. Ltd.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Financial Overview
    • 12.8.4 Product Portfolio
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Pathway Genomics Corporation
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Overview
    • 12.9.4 Product Portfolio
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 CENTOGENE AG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Financial Overview
    • 12.10.4 Product Portfolio
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

LIST OF TABLES

  • Table 1. CPT Codes for Hereditary Cancer Tests
  • Table 2. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 3. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 4. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 5. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 6. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 7. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 8. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 9. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 10. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 11. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 12. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 13. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 14. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 15. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 16. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 17. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 18. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 19. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 20. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 21. Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 22. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 23. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 24. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 25. UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 26. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 27. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 28. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 29. Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 30. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 31. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 32. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 33. France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 34. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 35. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 36. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 37. Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 38. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 39. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 40. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 41. Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 42. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 43. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 44. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 45. Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 46. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 47. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 48. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 49. China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 50. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 51. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 52. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 53. India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 54. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 55. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 56. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 57. Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 58. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 59. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 60. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 61. Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 62. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 63. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 64. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 65. South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 66. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 67. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 68. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 69. Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 70. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 71. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 72. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 73. South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 74. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 75. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 76. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 77. Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 78. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 79. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 80. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 81. UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 82. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 83. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 84. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 85. South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 86. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 87. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 88. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 89. Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 90. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
  • Table 91. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
  • Table 92. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
  • Table 93. Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • Table 94. Recent Product Launch in the Hereditary Cancer Testing Market
  • Table 95. Recent Product Approval in the Hereditary Cancer Testing Market
  • Table 96. Recent Other Growth Strategies in the Hereditary Cancer Testing Market
  • Table 97. Partnerships in the Hereditary Cancer Testing Market
  • Table 98. Agreement & Collaboration in the Hereditary Cancer Testing Market
  • Table 99. Acquisitions in the Hereditary Cancer Testing Market
  • Table 100. Glossary of Terms, Hereditary Cancer Testing Market

LIST OF FIGURES

  • Figure 1. Hereditary Cancer Testing Market Segmentation
  • Figure 2. Hereditary Cancer Testing Market Segmentation, by Region
  • Figure 3. Global Hereditary Cancer Testing Market Overview
  • Figure 4. Imaging Segment Held Largest Share Of The Diagnosis Type Segment In Hereditary Cancer Testing Market
  • Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Hereditary Cancer Testing Market, By Geography (US$ Mn)
  • Figure 7. Global Hereditary Cancer Testing Market- Leading Country Markets (US$ Mn)
  • Figure 8. Global Hereditary Cancer Testing Market, Industry Landscape
  • Figure 9. North America : PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia - Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Impact Analysis of Driver and Restraints Pertaining to Hereditary Cancer Testing Market
  • Figure 15. Global Hereditary Cancer Testing Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 16. Global Hereditary Cancer Testing Market - by Geography Forecasts and Analysis - 2018- 2027
  • Figure 17. Prominent Players in the Hereditary Cancer Testing Market
  • Figure 18. Global Hereditary Cancer Testing Market, by Diagnosis Type 2018 & 2027 (%)
  • Figure 19. Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 20. Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 22. Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 23. Global Hereditary Cancer Testing Market, by Technology 2018 & 2027 (%)
  • Figure 24. Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 25. Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 26. Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 27. Global Hereditary Cancer Testing Market, by End User 2018 & 2027 (%)
  • Figure 28. Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 29. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 30. Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 31. North America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 32. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 34. US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 35. Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 36. Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 37. Europe Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 38. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 40. UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 42. France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Asia Pacific Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 46. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 48. China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 49. India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 50. Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 51. Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 52. South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 53. Middle East & Africa Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 54. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 55. Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 56. South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 57. Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 58. UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 59. South and Central America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
  • Figure 60. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 61. South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 62. Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 63. Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 64. Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
  • Figure 65. Organic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
  • Figure 66. Inorganic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Back to Top